Hervé Christophe, Fondrevez Marc, Chéron Angélique, Barloy-Hubler Frédérique, Jan Gwénaël
Laboratoires Standa, UMR-STLO, 65 rue de Saint-Brieuc, 35042 RENNES cedex, France.
Int J Food Microbiol. 2007 Feb 15;113(3):303-14. doi: 10.1016/j.ijfoodmicro.2006.08.013. Epub 2006 Dec 5.
Dairy propionibacteria have recently been considered as probiotics which may beneficially modulate the intestinal ecosystem. However, appropriate vectors (food matrices containing the probiotic) which preserve their viability and offer good tolerance towards digestive stresses need to be developed. In addition, the development of efficient non-invasive methods which specifically monitor Propionibacterium freudenreichii concentration and activity within the human gut is required. To address this latter need, an enzyme involved in propionic fermentation, transcarboxylase, was evaluated in this study as molecular marker in P. freudenreichii. In vitro, the three transcarboxylase subunits were shown to be encoded by an operon and their expression regulated. It occurred during propionic fermentation, ceased in starved cells and was not affected by digestive stresses. The 5S subunit gene of transcarboxylase allowed specific detection of P. freudenreichii by real time PCR in the complex human faecal microbiota. A dairy vector harbouring P. freudenreichii was developed and afforded elevated probiotic faecal concentrations in humans. In vivo, this PCR method allowed rapid quantification of faecal P. freudenreichii in agreement with the cultural method (cfu counting). Moreover, real time Reverse Transcription (RT) -PCR evidenced transcription of the 5S subunit gene during transit through the human digestive tract. This work constitutes a methodological advance for survival and activity evaluation in human trials of the probiotics belonging to the P. freudenreichii species. It strongly suggests that this bacterium not only survives but remains metabolically active in the human gut.
乳源丙酸杆菌最近被认为是一种益生菌,可能对肠道生态系统产生有益的调节作用。然而,需要开发合适的载体(含有益生菌的食物基质)来保持其活力,并使其对消化应激具有良好的耐受性。此外,还需要开发高效的非侵入性方法,以特异性监测弗氏丙酸杆菌在人体肠道内的浓度和活性。为满足后一项需求,本研究评估了一种参与丙酸发酵的酶——转羧酶,作为弗氏丙酸杆菌的分子标记。在体外,三个转羧酶亚基由一个操纵子编码并受其表达调控。这种调控发生在丙酸发酵过程中,在饥饿细胞中停止,且不受消化应激的影响。转羧酶的5S亚基基因可通过实时PCR在复杂的人体粪便微生物群中特异性检测弗氏丙酸杆菌。开发了一种携带弗氏丙酸杆菌的乳制品载体,可使人粪便中的益生菌浓度升高。在体内,这种PCR方法能够与培养法(菌落形成单位计数)一致地快速定量粪便中的弗氏丙酸杆菌。此外,实时逆转录(RT)-PCR证明了5S亚基基因在通过人体消化道的过程中发生转录。这项工作为弗氏丙酸杆菌属益生菌在人体试验中的存活和活性评估提供了方法学上的进展。它有力地表明,这种细菌不仅能在人体肠道内存活,而且仍具有代谢活性。